APA (7th ed.) Citation

Gargiulo, P., Dietrich, D., Herrmann, R., Bodoky, G., Ruhstaller, T., Scheithauer, W., . . . Brauchli, P. (2019). Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: The APC-SAKK risk scores. SAGE Publishing.

Chicago Style (17th ed.) Citation

Gargiulo, Piera, et al. Predicting Mortality and Adverse Events in Patients with Advanced Pancreatic Cancer Treated with Palliative Gemcitabine-based Chemotherapy in a Multicentre Phase III Randomized Clinical Trial: The APC-SAKK Risk Scores. SAGE Publishing, 2019.

MLA (9th ed.) Citation

Gargiulo, Piera, et al. Predicting Mortality and Adverse Events in Patients with Advanced Pancreatic Cancer Treated with Palliative Gemcitabine-based Chemotherapy in a Multicentre Phase III Randomized Clinical Trial: The APC-SAKK Risk Scores. SAGE Publishing, 2019.